The Social Health Authority (SHA), will launch an overseas treatment package on April 14th, 2026 allowing Kenyan patients to access medical treatment abroad when services are not available locally.
SHA signed an agreement with nine overseas hospitals in India, Turkey and Saudi Arabia to give better health treatment to people as it will give benefit to Kenyans.
According to SHA CEO Mercy Mwangangi, she said this will give benefit package to patients who will travel in those countries as they be able to access SHA. The government has signed deals with four hospitals in Turkey under the Acıbadem Healthcare Group.
The first is Acıbadem Mehmet Ali Aydınlar University Atakent Hospital, specializes in oncology, cardiovascular surgery, organ transplants, and robotic surgery.
The second, Acıbadem Maslak Hospital, is known for its comprehensive cancer care, including MR-Linac radiation technology, spine health, and robotic-assisted surgery.
The third, Acıbadem Altunizade Hospital, specializes in neurological sciences, cell therapy, and bone marrow transplantation.
The fourth is Acıbadem Adana Hospital, a regional facility with dedicated units for pediatric oncology, pediatric hematology, a paediatric bone marrow transplant Centre, IVF, and cardiovascular surgery.
In India, two hospitals were contracted: KIMS Hospitals specialises in cardiac sciences, organ transplantation, neurosciences, and quaternary care.
The second hospital, Apollo Proton Cancer Centre in Chennai, specialising in oncology suite spanning surgical, radiation, and medical oncology, with robotic surgery as a central component of its cancer management model.
Saudi Arabia, Dr Soliman Fakeeh Hospital in Jeddah, offers neurosurgery and comprehensive organ transplant services.
The King Faisal Specialist Hospital and Research Centre known for complex oncology, organ transplantation, genomic medicine, and neurosciences.
Health CS Aden Duale said SHA will only cover treatment costs for medical procedures which are not available in Kenya.
Only 36 specific procedures not available in Kenya will be covered, with a maximum limit of Ksh 500,000 per patient.
